北京市天元律师事务所 关于天津捷强动力装备股份有限公司 2024 年年度股东会的法律意见 京天股字（2025）第 257 号 致：天津捷强动力装备股份有限公司 天津捷强动力装备股份有限公司（以下简称"公司"）2024 年年度股东会（以下 简称"本次股东会"）采取现场投票与网络投票相结合的方式，现场会议于 2025 年 5 月 20 日（星期二）14:30 在天津市北辰区滨湖路 3 号公司会议室召开。北京市天 元律师事务所（以下简称"本所"）接受公司聘任，指派本所律师参加本次股东会现 场会议，并根据《中华人民共和国公司法》、《中华人民共和国证券法》（以下简 称"《证券法》"）、《上市公司股东会规则》（以下简称"《股东会规则》"）以及 《天津捷强动力装备股份有限公司章程》（以下简称"《公司章程》"）等有关规定， 就本次股东会的召集、召开程序、出席现场会议人员的资格、召集人资格、会议表 决程序及表决结果等事项出具本法律意见。 为出具本法律意见，本所律师审查了《天津捷强动力装备股份有限公司第四届董 事会第四次会议决议公告》《天津捷强动力装备股份有限公司第四届监事会第四次会 议决议公告》《天津捷强动力装备股份有限公司关 ...

证券代码：300875 证券简称：捷强装备 公告编号：2025-021 天津捷强动力装备股份有限公司 2024年年度股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1.本次股东会未出现增加、变更或否决议案的情况； 2.本次股东会不涉及变更以往股东会已通过决议的情况。 一、会议召开和出席的情况 （一）会议召开情况 1.会议通知：天津捷强动力装备股份有限公司（以下简称"公司"）董事会 于2025年4月29日在中国证监会指定创业板信息披露网站刊登了《天津捷强动力 装备股份有限公司关于召开2024年年度股东会的通知》（公告编号：2025-018） 的公告。 2.会议召开时间： 7.本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件 和公司章程等的规定。 （二）会议出席情况 （1）现场会议召开时间：2025年5月20日（星期二）下午14:30 （2）网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年5月20日 上午9:15-9:25，9:30-11:30，下午13:00-15:00； 通过深圳证券交易 ...

Core Viewpoint - The company aims to enhance its performance by focusing on core business areas, strategic collaboration, and industry upgrades in the nuclear and biochemical safety sector [1][2]. Group 1: Business Strategy - The company will continue to "focus on core business" by improving its management system centered around sales and after-sales, while accelerating market layout through key projects [1]. - The company emphasizes "strategic collaboration" to strengthen business synergy between the company and its subsidiaries, integrating product systems and completing brand iterations [1]. - The company is committed to "industry upgrades" by providing customized solutions and integrating various technologies and products in public safety, environmental protection, and healthcare [1]. Group 2: Industry Focus - The company specializes in nuclear and biochemical safety, with applications in nuclear radiation safety, biological safety, and chemical safety [1]. - The rapid development of the nuclear and biochemical safety equipment sector is driven by the acceleration of national nuclear energy strategies and advancements in healthcare and environmental protection [1]. - The company has been enhancing its product structure and variety, leading to new growth opportunities in market expansion [1]. Group 3: Future Goals - The company aims to establish an "integrated nuclear and biochemical safety equipment and service system" to provide comprehensive solutions and specialized value services [2]. - The strategic goal is to become a benchmark enterprise in the nuclear and biochemical safety field, positioning itself as a provider of comprehensive solutions and high-end equipment [2]. - By 2025, the company plans to continue its focus on R&D, production, sales, and technical services in nuclear and biochemical safety equipment, aiming to expand revenue and enhance core competitiveness [2].

Group 1: Industry Performance and Outlook - The nuclear biochemical safety industry is experiencing rapid growth, with applications expanding across various sectors such as environmental protection, healthcare, and military [3] - The company emphasizes the importance of nuclear biochemical safety equipment, which is characterized by its ability to respond quickly in emergencies and ensure safety during peacetime [3] - The future of nuclear technology applications in China is expected to maintain strong growth momentum, with continuous expansion of application fields and scales [3] Group 2: Company Strategy and Measures - The company is focusing on core business areas, enhancing management systems, and accelerating market layout to address ongoing losses [3][5] - Strategic collaboration and integration of product systems are key to improving operational efficiency and achieving brand iteration [3] - The company aims to become a benchmark enterprise in the nuclear biochemical safety field, providing comprehensive solutions and specialized services [5] Group 3: Financial Performance and Goals - The management is committed to improving profitability and aims for significant recovery in performance in the upcoming year [5] - The company plans to expand revenue scale, optimize asset utilization, and enhance core competitiveness to achieve sustainable profitability [5] - Continuous upgrades in business layout, product systems, and marketing strategies are essential for future growth [5]

| | 2024 年 | 2023 年 | 本年比上年增减 | 2022 年 | | --- | --- | --- | --- | --- | | 营业收入(元) | 138,383,225.40 | 293, 242, 986. 75 | -52. 81% | 239,885,868.92 | | 归属于上市公司股东 | -278, 257, 146. 88 | -67,904,243.29 | -309. 78% | -17,425,570.59 | | 的净利润(元) | | | | | | 归属于上市公司股东 的扣除非经常性损益 | -291,511,558.23 | -111, 970, 497. 90 | -160. 35% | -33,099,782.38 | | 的净利润(元) | | | | | | 经营活动产生的现金 | -36, 120, 019. 80 | 492, 058. 76 | -7, 440. 59% | -123, 179, 586. 99 | | 流量净额(元) | | | | | | 基本每股收益(元/ | -2. 80 | -0. 68 | -311. 76% | ...

Core Viewpoint - Tianjin Jieqiang Power Equipment Co., Ltd. has faced significant financial challenges, reporting a net loss of 278 million yuan in 2024, marking a 309.78% year-on-year increase in losses, and accumulating total losses of 363 million yuan over three years [1][3][4] Financial Performance - In 2024, the company's total revenue plummeted by 52.81% to 138 million yuan, continuing a downward trend since 2022 [1][4] - The net profit attributable to shareholders has shown a consistent decline, with losses of 17 million yuan in 2022, 68 million yuan in 2023, and 278 million yuan in 2024, reflecting year-on-year decreases of 156.22%, 289.68%, and 309.78% respectively [3][4] Product Line Performance - The hydraulic power system, which previously accounted for over 90% of revenue, saw its income drop from 243 million yuan in 2020 to a negative 63.4 million yuan in 2024, indicating a severe decline in this core business [1][6] - Other product lines, including biological detection equipment and nuclear biochemical safety equipment, also experienced significant revenue declines in 2024, with biological detection equipment revenue falling to 7.36 million yuan (down 3.43%) and nuclear biochemical safety equipment revenue down 39.01% to 56.99 million yuan [7][8] Asset Impairment - The company has recorded substantial asset impairment losses, totaling 290 million yuan over four years, which has severely impacted profitability [8][9] - In 2024, asset impairments increased by 181.54% to 160.27 million yuan, driven by goodwill impairment, inventory impairment, and accounts receivable impairment [4][9] Cash Flow Situation - The company reported a net cash outflow from operating activities of -36.12 million yuan in 2023, a drastic decline of 7440.59% year-on-year, primarily due to reduced sales collections [4][8] - Overall, the net increase in cash and cash equivalents was -183.81 million yuan, a decrease of 90.48% compared to the previous year [4]

Market Overview - The Shanghai Composite Index closed at 3342.67 points, above the annual line, with a gain of 0.80% [1] - The total trading volume of A-shares reached 15050.72 billion yuan [1] Stocks Breaking Annual Line - A total of 98 A-shares have surpassed the annual line today, with notable stocks including Jinpu Titanium, Sanxiang Impression, and Houpu Co., which have deviation rates of 9.12%, 8.94%, and 7.94% respectively [1] - Stocks with smaller deviation rates that just crossed the annual line include ChuanTou Energy, Hongta Securities, and Jinbin Development [1] Top Stocks by Deviation Rate - Jinpu Titanium (000545) saw a price increase of 9.81% with a turnover rate of 6.51%, latest price at 2.35 yuan, deviation rate of 9.12% [1] - Sanxiang Impression (000863) increased by 10.14% with a turnover rate of 3.85%, latest price at 4.02 yuan, deviation rate of 8.94% [1] - Houpu Co. (300471) rose by 8.78% with a turnover rate of 10.22%, latest price at 9.91 yuan, deviation rate of 7.94% [1] Additional Stocks with Notable Performance - Bojie Co. (002975) increased by 9.99% with a turnover rate of 3.33%, latest price at 32.81 yuan, deviation rate of 7.25% [1] - Hangxin Technology (300424) rose by 6.12% with a turnover rate of 11.08%, latest price at 15.78 yuan, deviation rate of 5.43% [1] - Other notable stocks include Zhonghang Shenfei (600760) and Hongye Futures (001236) with deviation rates of 4.48% and 3.52% respectively [1]

证券代码：300875 证券简称: 捷强装备 公告编号：2025-018 天津捷强动力装备股份有限公司 关于召开 2024 年年度股东会的通知 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 3、会议召开的合法、合规性：本次股东会的召集、召开符合有关法律、行政 法规、部门规章、其他规范性文件及《公司章程》的有关规定。 4、会议召开的日期与时间 （1）现场会议召开时间：2025 年 5 月 20 日（星期二）14:30 开始 （2）网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 20 日 9:15—9:25，9:30—11:30，13:00—15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 5 月 20 日 上午 9:15—下午 15:00 期间的任意时间。 5、会议的召开方式：本次股东会采取现场投票与网络投票相结合的方式召开。 天津捷强动力装备股份有限公司（以下简称"公司"或"本公司"）于 2025 年 4 月 27 日召开了第四届董事会第四次会议，审议通过了《关于召开 2024 年年 度股东会的 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 证券代码：300875 证券简称：捷强装备 公告编号：2025-006 天津捷强动力装备股份有限公司 第四届董事会第四次会议决议公告 天津捷强动力装备股份有限公司（以下简称"公司"）第四届董事会第四次 会议通知已于 2025 年 4 月 16 日通过书面方式送达。会议于 2025 年 4 月 27 日以 现场结合通讯表决方式在公司会议室召开。本次会议应出席董事 9 名，实际出席 董事 9 名，其中董事郭俊鹏先生、独立董事何锦成先生、方吉祥先生、易宏先生 以通讯方式出席会议。会议由董事长潘淇靖先生召集并主持，公司监事、高级管 理人员列席了会议。本次会议的召开和表决程序符合《中华人民共和国公司法》 （以下简称"《公司法》"）等法律、法规、规范性文件和《公司章程》等的有 关规定，会议合法、有效。 二、董事会会议审议情况 与会董事审议通过了如下议案： 1、审议通过了《关于<2024 年度总经理工作报告>的议案》； 与会董事审议了总经理潘淇靖先生提交的《2024 年度总经理工作报告》，一 致认为：在 ...